ANIP
ANI PHARMACEUTICALS INC
+1.08 (+1.47%)74.67USD138K成交股數1.8B市值16.2本益比(近四季)1.9股價營收比+25.9%營收年增(近四季)2026-11-06下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 11 · 2.2M · 5 |
| 其中 10b5-1 計畫賣出 | 10 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 8.4M |
| 近 180 天 淨額 | −8.4M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Lalwani Nikhil | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 5.4K | 71.00 | 383K | 339K | SEC |
| 2026-09-14 | 09-14 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 70.79 | 35K | 73.9K | SEC |
| 2026-09-11 | 09-14 | Thoma Jeanne | Director | S 公開市場賣出(10b5-1) | 1.0K | 71.53 | 72K | 26.8K | SEC |
| 2026-08-31 | 09-01 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出(10b5-1) | 2.9K | 72.80 | 207K | 172K | SEC |
| 2026-08-25 | 08-26 | Lalwani Nikhil | PRESIDENT & CEO | S 公開市場賣出(10b5-1) | 5.4K | 74.30 | 401K | 344K | SEC |
| 2026-08-19 | 08-27 | Gosebruch Henry O | Director | A 獲配股票 | 6.7K | – | – | 6.7K | SEC |
| 2026-08-13 | 08-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 75.48 | 38K | 74.4K | SEC |
| 2026-08-10 | 08-11 | Gutwerg Ori | SVP, GENERICS | S 公開市場賣出 | 3.2K | 77.00 | 243K | 75.5K | SEC |
| 2026-07-29 | 07-30 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出(10b5-1) | 2.9K | 81.36 | 232K | 175K | SEC |
| 2026-07-18 | 07-21 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F 繳稅扣股 | 2.5K | 79.20 | 195K | 74.9K | SEC |
| 2026-07-13 | 07-14 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 81.84 | 41K | 77.4K | SEC |
| 2026-07-02 | 07-06 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出(10b5-1) | 3.3K | 86.00 | 285K | 178K | SEC |
| 2026-07-02 | 07-06 | CAREY STEPHEN P. | SVP & CFO | M 選擇權執行 | 3.3K | 49.51 | 164K | 181K | SEC |
| 2026-06-29 | 06-30 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出(10b5-1) | 2.9K | 84.12 | 240K | 178K | SEC |
| 2026-06-12 | 06-15 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 82.03 | 41K | 77.9K | SEC |
| 2026-06-08 | 06-10 | HAUGHEY THOMAS | Director | S 公開市場賣出(10b5-1) | 2.0K | 80.88 | 162K | 38.9K | SEC |
| 2026-06-05 | 06-09 | CAREY STEPHEN P. | SVP & CFO | M 選擇權執行 | 3.3K | 49.51 | 164K | 184K | SEC |
| 2026-06-05 | 06-09 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出(10b5-1) | 3.3K | 80.00 | 265K | 180K | SEC |
| 2026-05-21 | 06-10 | HAUGHEY THOMAS | Director | A 獲配股票 | 4.4K | – | – | 40.9K | SEC |
| 2026-05-21 | 06-10 | TANNENBAUM RENEE P | Director | A 獲配股票 | 4.4K | – | – | 29.5K | SEC |
| 2026-05-21 | 06-10 | Thoma Jeanne | Director | A 獲配股票 | 4.4K | – | – | 27.8K | SEC |
| 2026-05-21 | 06-10 | Leonard Matthew J | Director | A 獲配股票 | 4.4K | – | – | 11.2K | SEC |
| 2026-05-21 | 06-10 | Pera Antonio R | Director | A 獲配股票 | 4.4K | – | – | 27.0K | SEC |
| 2026-05-13 | 05-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 78.16 | 39K | 78.4K | SEC |
| 2026-05-13 | 05-13 | Walsh Patrick D | Director | S 公開市場賣出 | 10.0K | 80.63 | 806K | 38.4K | SEC |
| 2026-05-12 | 05-13 | Gutwerg Ori | SVP, GENERICS | S 公開市場賣出 | 2.8K | 79.50 | 220K | 78.7K | SEC |
| 2026-05-12 | 05-13 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S 公開市場賣出 | 459 | 79.21 | 36K | 38.3K | SEC |
| 2026-05-11 | 05-13 | Lalwani Nikhil | PRESIDENT & CEO | S 公開市場賣出 | 55.0K | 77.57 | 4.3M | 350K | SEC |
| 2026-05-11 | 05-13 | Walsh Patrick D | Director | S 公開市場賣出 | 4.0K | 80.75 | 321K | 48.4K | SEC |
| 2026-04-13 | 04-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 77.95 | 39K | 78.9K | SEC |
| 2026-03-13 | 03-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 72.62 | 36K | 79.4K | SEC |
| 2026-03-13 | 03-13 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 3.2K | 71.64 | 227K | 91.3K | SEC |
| 2026-03-11 | 03-13 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S 公開市場賣出 | 4.8K | 74.91 | 357K | 38.7K | SEC |
| 2026-03-09 | 03-10 | Davis Krista | SVP, CHIEF HR OFFICER | S 公開市場賣出(10b5-1) | 5.1K | 74.13 | 377K | 51.9K | SEC |
| 2026-03-09 | 03-10 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 3.6K | 74.18 | 267K | 94.5K | SEC |
| 2026-03-07 | 03-10 | CAREY STEPHEN P. | SVP & CFO | F 繳稅扣股 | 5.2K | 74.04 | 381K | 180K | SEC |
| 2026-03-07 | 03-10 | Mutz Christopher | HEAD OF RARE DISEASE | F 繳稅扣股 | 3.3K | 74.04 | 245K | 98.1K | SEC |
| 2026-03-07 | 03-10 | Gutwerg Ori | SVP, GENERICS | F 繳稅扣股 | 3.3K | 74.04 | 245K | 81.5K | SEC |
| 2026-03-07 | 03-10 | Lalwani Nikhil | PRESIDENT & CEO | F 繳稅扣股 | 17.1K | 74.04 | 1.3M | 405K | SEC |
| 2026-03-06 | 03-10 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 2.1K | 74.22 | 157K | 101K | SEC |
| 2026-03-06 | 03-10 | Davis Krista | SVP, CHIEF HR OFFICER | S 公開市場賣出(10b5-1) | 1.5K | 75.00 | 111K | 57.0K | SEC |
| 2026-03-05 | 03-05 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出 | 3.3K | 75.42 | 250K | 190K | SEC |
| 2026-03-05 | 03-05 | CAREY STEPHEN P. | SVP & CFO | M 選擇權執行 | 3.3K | 49.51 | 164K | 193K | SEC |
| 2026-03-05 | 03-05 | CAREY STEPHEN P. | SVP & CFO | S 公開市場賣出 | 4.0K | 75.56 | 302K | 186K | SEC |
| 2026-03-03 | 03-04 | Gutwerg Ori | SVP, GENERICS | S 公開市場賣出 | 2.1K | 76.50 | 158K | 84.8K | SEC |
| 2026-03-03 | 03-03 | Walsh Patrick D | Director | S 公開市場賣出 | 6.0K | 74.23 | 445K | 52.4K | SEC |
| 2026-03-02 | 03-04 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 417 | 74.00 | 31K | 104K | SEC |
| 2026-02-28 | 03-02 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F 繳稅扣股 | 2.2K | 73.90 | 164K | 74.9K | SEC |
| 2026-02-28 | 03-02 | Mutz Christopher | HEAD OF RARE DISEASE | F 繳稅扣股 | 2.2K | 73.90 | 164K | 104K | SEC |
| 2026-02-28 | 03-02 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F 繳稅扣股 | 628 | 73.90 | 46K | 43.5K | SEC |
| 2026-02-28 | 03-02 | Lalwani Nikhil | PRESIDENT & CEO | F 繳稅扣股 | 12.2K | 73.90 | 903K | 422K | SEC |
| 2026-02-28 | 03-02 | CAREY STEPHEN P. | SVP & CFO | F 繳稅扣股 | 2.8K | 73.90 | 205K | 190K | SEC |
| 2026-02-28 | 03-02 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F 繳稅扣股 | 1.6K | 73.90 | 115K | 79.9K | SEC |
| 2026-02-28 | 03-02 | Gutwerg Ori | SVP, GENERICS | F 繳稅扣股 | 2.2K | 73.90 | 164K | 86.8K | SEC |
| 2026-02-28 | 03-02 | Davis Krista | SVP, CHIEF HR OFFICER | F 繳稅扣股 | 1.6K | 73.90 | 115K | 58.5K | SEC |
| 2026-02-26 | 03-02 | Davis Krista | SVP, CHIEF HR OFFICER | A 獲配股票 | 10.8K | 77.15 | 834K | 60.1K | SEC |
| 2026-02-26 | 03-02 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | A 獲配股票 | 13.9K | 77.15 | 1.1M | 81.4K | SEC |
| 2026-02-26 | 03-02 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | A 獲配股票 | 11.1K | 77.15 | 858K | 77.1K | SEC |
| 2026-02-26 | 03-02 | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A 獲配股票 | 11.1K | 77.15 | 858K | 101K | SEC |
| 2026-02-26 | 03-02 | Mutz Christopher | HEAD OF RARE DISEASE | A 獲配股票 | 21.3K | 77.15 | 1.6M | 106K | SEC |
| 2026-02-26 | 03-02 | Gutwerg Ori | SVP, GENERICS | A 獲配股票 | 13.0K | 77.15 | 1.0M | 89.1K | SEC |
| 2026-02-26 | 03-02 | Lalwani Nikhil | PRESIDENT & CEO | A 獲配股票 | 75.6K | 77.15 | 5.8M | 434K | SEC |
| 2026-02-26 | 03-02 | CAREY STEPHEN P. | SVP & CFO | A 獲配股票 | 22.2K | 77.15 | 1.7M | 192K | SEC |
| 2026-02-26 | 03-02 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A 獲配股票 | 6.0K | 77.15 | 465K | 44.1K | SEC |
| 2026-02-20 | 02-23 | Davis Krista | SVP, CHIEF HR OFFICER | S 公開市場賣出(10b5-1) | 1.7K | 77.99 | 135K | 49.3K | SEC |
| 2026-02-20 | 02-23 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 5.3K | 78.02 | 415K | 84.8K | SEC |
| 2026-02-19 | 02-23 | Davis Krista | SVP, CHIEF HR OFFICER | S 公開市場賣出(10b5-1) | 2.1K | 77.53 | 162K | 51.0K | SEC |
| 2026-02-14 | 02-17 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F 繳稅扣股 | 1.7K | 77.36 | 133K | 66.0K | SEC |
| 2026-02-14 | 02-17 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F 繳稅扣股 | 1.8K | 77.36 | 138K | 67.5K | SEC |
| 2026-02-14 | 02-17 | Davis Krista | SVP, CHIEF HR OFFICER | F 繳稅扣股 | 1.3K | 77.36 | 100K | 53.1K | SEC |
| 2026-02-14 | 02-17 | Gutwerg Ori | SVP, GENERICS | F 繳稅扣股 | 1.9K | 77.36 | 146K | 76.1K | SEC |
| 2026-02-14 | 02-17 | Lalwani Nikhil | PRESIDENT & CEO | F 繳稅扣股 | 10.3K | 77.36 | 797K | 359K | SEC |
| 2026-02-14 | 02-17 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F 繳稅扣股 | 485 | 77.36 | 38K | 38.1K | SEC |
| 2026-02-14 | 02-17 | Mutz Christopher | HEAD OF RARE DISEASE | F 繳稅扣股 | 2.4K | 77.36 | 186K | 90.2K | SEC |
| 2026-02-14 | 02-17 | CAREY STEPHEN P. | SVP & CFO | F 繳稅扣股 | 2.4K | 77.36 | 189K | 170K | SEC |
| 2026-02-13 | 02-17 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S 公開市場賣出(10b5-1) | 500 | 76.80 | 38K | 69.3K | SEC |
| 2026-02-12 | 02-17 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | F 繳稅扣股 | 1.6K | 76.70 | 123K | 67.7K | SEC |
| 2026-02-12 | 02-17 | Mutz Christopher | HEAD OF RARE DISEASE | S 公開市場賣出(10b5-1) | 7.0K | 76.55 | 538K | 92.6K | SEC |
| 2026-02-12 | 02-17 | Mutz Christopher | HEAD OF RARE DISEASE | F 繳稅扣股 | 3.2K | 76.70 | 243K | 99.6K | SEC |
| 2026-02-12 | 02-17 | Gutwerg Ori | SVP, GENERICS | F 繳稅扣股 | 1.8K | 76.70 | 136K | 78.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 3.0M | 245M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 868K | 71.8M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 838K | 69.4M | 新進 | 新進 |
| STATE STREET CORP | 832K | 68.9M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 708K | 58.6M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 623K | 51.6M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 574K | 47.6M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 562K | 46.5M | 新進 | 新進 |
| Global Alpha Capital Management Ltd. | 558K | 46.2M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 536K | 44.4M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 507K | 42.0M | 新進 | 新進 |
| Nuveen, LLC | 415K | 34.4M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 407K | 33.7M | 新進 | 新進 |
| Ranger Investment Management, L.P. | 343K | 28.4M | 新進 | 新進 |
| DEUTSCHE BANK AG\ | 323K | 26.8M | 新進 | 新進 |
| Invesco Ltd. | 309K | 25.6M | 新進 | 新進 |
| UBS Group AG | 298K | 24.6M | 新進 | 新進 |
| KENNEDY CAPITAL MANAGEMENT LLC | 296K | 24.5M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 287K | 23.8M | 新進 | 新進 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 287K | 23.8M | 新進 | 新進 |
| Ikarian Capital, LLC | 272K | 22.5M | 新進 | 新進 |
| Aberdeen Group plc | 272K | 22.5M | 新進 | 新進 |
| OBERWEIS ASSET MANAGEMENT INC/ | 265K | 22.0M | 新進 | 新進 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 258K | 21.4M | 新進 | 新進 |
| Rubric Capital Management LP | 258K | 21.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 307 +26 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 307 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 23.0M · 94.1% |
| 合計季末市值 | 1.9B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.4M |
|---|---|
| 與上期比 | -1.6% |
| 佔流通股數 | 13.78% |
| 日均成交量 | 365K |
| 回補天數 | 9.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.4M | -1.6% | 13.78% | 365K | 9.2 |
| 2026-08-14 | 3.4M | +46.6% | 14.01% | 464K | 7.4 |
| 2026-07-31 | 2.3M | -30.8% | 9.56% | 252K | 9.3 |
| 2026-07-15 | 3.4M | -2.1% | 13.80% | 307K | 11.0 |
| 2026-06-30 | 3.4M | +7.5% | 14.09% | 365K | 9.4 |
| 2026-06-15 | 3.2M | -3.7% | 13.11% | 293K | 10.9 |
| 2026-05-29 | 3.3M | -8.2% | 13.61% | 336K | 9.9 |
| 2026-05-15 | 3.6M | +1.7% | 14.83% | 470K | 7.7 |
| 2026-04-30 | 3.6M | +2.0% | 14.59% | 275K | 13.0 |
| 2026-04-15 | 3.5M | -2.6% | 14.30% | 396K | 8.8 |
| 2026-03-31 | 3.6M | -0.5% | 14.68% | 298K | 12.0 |
| 2026-03-13 | 3.6M | +2.1% | 14.76% | 457K | 7.9 |
| 2026-02-27 | 3.5M | +2.8% | 14.45% | 294K | 12.0 |
| 2026-02-13 | 3.4M | -1.2% | 14.05% | 338K | 10.2 |
| 2026-01-30 | 3.5M | +18.0% | 14.22% | 497K | 7.0 |
| 2026-01-15 | 2.9M | -0.6% | 12.06% | 622K | 4.7 |
| 2025-12-31 | 3.0M | +11.0% | 12.13% | 427K | 6.9 |
| 2025-12-15 | 2.7M | -6.3% | 10.93% | 390K | 6.9 |
| 2025-11-28 | 2.8M | +14.5% | 11.66% | 482K | 5.9 |
| 2025-11-14 | 2.5M | -0.8% | 10.18% | 415K | 6.0 |
| 2025-10-31 | 2.5M | +5.4% | 10.26% | 395K | 6.3 |
| 2025-10-15 | 2.4M | +1.8% | 9.73% | 258K | 9.2 |
| 2025-09-30 | 2.3M | +13.9% | 9.55% | 338K | 6.9 |
| 2025-09-15 | 2.0M | +0.3% | 8.39% | 402K | 5.1 |
| 2025-08-29 | 2.0M | -7.2% | 8.36% | 471K | 4.3 |
| 2025-08-15 | 2.2M | -0.4% | 9.01% | 951K | 2.3 |